Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

SOLX Gold Shunt for Refractory Glaucoma

ClinicalTrials.gov ID: NCT01282346

Public ClinicalTrials.gov record NCT01282346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To establish the clinical performance of the SOLX Gold Shunt for its ability to reduce intraocular pressure (IOP) in eyes with refractory glaucoma where medical and conventional surgical treatments have failed.

Study identification

NCT ID
NCT01282346
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
SOLX, Inc.
Industry
Enrollment
116 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2010
Primary completion
Nov 30, 2015
Completion
Nov 30, 2015
Last update posted
Feb 22, 2017

2011 – 2015

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35233
Vold Vision, PLLC Springdale Arkansas 72762
University of California, Irvine Irvine California 92697
Yale University New Haven Connecticut 06510
Illinois Eye Institute Chicago Illinois 60616
Glaucoma Associates of New York New York New York 10003
Ophthalmic Partners of Pennsylvania Bala-Cynwyd Pennsylvania 19004
University Eye Surgeons Maryville Tennessee 37803
Glaucoma Associates of Texas Dallas Texas 75231
University of Virginia Charlottsville Virginia 22908
Memmen, Ltd Green Bay Wisconsin 54304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01282346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01282346 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →